Clinical Trial Update: Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial of SHR-1701 plus chemotherapy as perioperative treatment for locally advanced resectable gastric cancer or gastroesophageal junction cancer ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• SHR-1701

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer | Phase 2, Phase 3 | Status: TERMINATED